Watch the full panel video featuring our very own Dr. Chopra at LSI Europe 25
Dr. Chopra joined global medtech leaders as a featured presenter
We shared our ECMO innovation on stage at LSI USA '24 — a premier global medtech summit
Eleusô earned top recognition for simplifying and scaling critical care delivery
Ready to learn more about Eleusô? We'd love to hear from you.
Eleusô is eying applications for its pump platform that go beyond ECMO. The company's CEO says smart pumps that can be fine-tuned to patient volume an...
Read More
Eleusô, a company developing extracorporeal membrane oxygenation (ECMO) pump technology, has closed a $2.5 million Series A funding round. The investm...
Read More
Boston, MA – July 14, 2025 – Eleusô, a pioneer in extracorporeal membrane oxygenation (ECMO) pump innovation, today announced the successful close of...
Read More
Dr. Chopra MD Dip. Anat. FRACS MBA, is an experienced neurosurgeon and entrepreneur with more than 20 years of strategic advisory, investment, clinical research and operational experience in the healthcare sector across the medical device, diagnostic, services, information technology and pharma verticals. Dr. Chopra has worked with early stage as well as large cap private and public companies in developed and emerging markets and is is the co-founder, managing partner of TCG, an executive accelerator focused on cutting edge smart and personalized medical and wellness technologies.
Joe Kiani is a renowned technology entrepreneur and humanitarian, as well as the Founder of Masimo, one of the world's most admired medical technology companies. In 2012, Joe founded the Patient Safety Movement Foundation. The inventor of world-changing, noninvasive patient monitoring; and the recipient of multiple awards across the intellectual property, technology and humanitarian sectors; Joe speaks at events around the world, championing the rights of those who are not always empowered to speak for themselves.
Dr. Chopra MD Dip. Anat. FRACS MBA, is an experienced neurosurgeon and entrepreneur with more than 20 years of strategic advisory, investment, clinical research and operational experience in the healthcare sector across the medical device, diagnostic, services, information technology and pharma verticals. Dr. Chopra has worked with early stage as well as large cap private and public companies in developed and emerging markets and is is the co-founder, managing partner of TCG, an executive accelerator focused on cutting edge smart and personalized medical and wellness technologies.
Joe Kiani is a renowned technology entrepreneur and humanitarian, as well as the Founder of Masimo, one of the world's most admired medical technology companies. In 2012, Joe founded the Patient Safety Movement Foundation. The inventor of world-changing, noninvasive patient monitoring; and the recipient of multiple awards across the intellectual property, technology and humanitarian sectors; Joe speaks at events around the world, championing the rights of those who are not always empowered to speak for themselves.
Founder of Recurve Capital, Aaron has over 20 years of experience managing billions of dollars of client assets in Technology, Media, Telecom, and Consumer sectors. Aaron also serves as Chief Investment Officer of Kiani Preserve. He holds a BS from Stanford University.
Peter Aherne is a recognized leader in global debt capital markets, with extensive experience delivering innovative financial strategies and complex transaction structuring for industry-defining clients and institutions. He brings expertise in risk management, compliance, and collaborative stakeholder alignment, having overseen large-scale teams and led high-impact initiatives in capital raising. Peter’s extensive track record includes managing multi-billion-dollar deals and pioneering technology platforms that have transformed primary market operations.
Mr. Smith is currently the Co-Chief Executive Officer and CFO of CDX. He is the former CEO and a board member of BioScrip, Inc (merged with OptionCare)., a billion-dollar specialty pharmacy and alternate site infusion provider serving 40,000 patients monthly. Mr. Smith established industry leading clinical programs in heart failure, managing as many as 5,000 heart failure patients on a monthly basis. Mr. Smith, was previously CEO of Byram Healthcare Centers (now part of Owens and Minor) , President of OptionCare, CEO and CFO of Coram Healthcare (CVS) and private companies in accounting, treasury and taxation areas.
Peter Aherne is a recognized leader in global debt capital markets, with extensive experience delivering innovative financial strategies and complex transaction structuring for industry-defining clients and institutions. He brings expertise in risk management, compliance, and collaborative stakeholder alignment, having overseen large-scale teams and led high-impact initiatives in capital raising. Peter’s extensive track record includes managing multi-billion-dollar deals and pioneering technology platforms that have transformed primary market operations.
Mr. Smith is currently the Co-Chief Executive Officer and CFO of CDX. He is the former CEO and a board member of BioScrip, Inc (merged with OptionCare)., a billion-dollar specialty pharmacy and alternate site infusion provider serving 40,000 patients monthly. Mr. Smith established industry leading clinical programs in heart failure, managing as many as 5,000 heart failure patients on a monthly basis. Mr. Smith, was previously CEO of Byram Healthcare Centers (now part of Owens and Minor) , President of OptionCare, CEO and CFO of Coram Healthcare (CVS) and private companies in accounting, treasury and taxation areas.
